Published in
Royal Society of Chemistry, Chemical Communications, 85(58), p. 11913-11916, 2022
DOI: 10.1039/d2cc03135c
Links
Tools
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders
Journal article published in 2022 by
Federica Moraca 
,
Simona Marzano ,
Francesco D'Amico ,
Antonio Lupia,
Silvia Di Fonzo ,
Eleonora Vertecchi,
Erica Salvati,
Anna Di Porzio,
Bruno Catalanotti,
Antonio Randazzo ,
Bruno Pagano ,
Jussara Amato
,
Simona Marzano ,
Francesco D'Amico ,
Antonio Lupia,
Silvia Di Fonzo ,
Eleonora Vertecchi,
Erica Salvati,
Anna Di Porzio,
Bruno Catalanotti,
Antonio Randazzo ,
Bruno Pagano ,
Jussara Amato
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Ligand-based virtual screening and biophysical techniques have been used to identify FDA approved drugs able to bind and stabilize SARS-CoV-2 G-quadruplex-forming RNA and to provide the molecular basis of the interactions.